[ad_1]
The European Commission has approved a contract with the European pharmaceutical company “Kjurvak”, which provides for the initial purchase of 225 million doses of vaccine against kovid 19, with the possibility of delivering an additional 180 million doses when the vaccine proves to be safe and effective.
Source: Tanjug
Photo: deposiphotos / IgorVetushko
European Commission President Ursula von der Layen says the EC has so far provided 1.2 billion doses of potential covid vaccine and points out that the Covax tool is working to deliver vaccines to other low- and middle-income countries to ensure that all will be safe and quality holidays available.
The agreement with the company “Kjurvak” is the fifth contract that the Commission has signed on behalf of the Member States with pharmaceutical companies to supply a wide range of vaccines that will be produced in Europe.
Previously, contracts have been signed with “Astra Zenek”, “Sanofi”, “Jansen Pharmaceuticals” and “Pfizer”.
Preliminary talks on the purchase of 160 million doses of the vaccine, which will be manufactured by the “Moderna” company, have also been concluded, and which has so far shown 94.5 percent success in clinical trials.
“This diverse portfolio of vaccines will ensure that Europe is well prepared for vaccination once the vaccines prove safe and effective. Member States can also decide to donate the vaccine to low- and middle-income countries or redirect it to others. European countries, “says the statement. To the European Commission.
[ad_2]
Source link
